Giorgio Astara
About
Giorgio Astara is a scholar working on Oncology, Physiology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Giorgio Astara has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Physiology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giorgio Astara's work include Nutrition and Health in Aging (13 papers), Lung Cancer Research Studies (6 papers) and Head and Neck Cancer Studies (6 papers). Giorgio Astara is often cited by papers focused on Nutrition and Health in Aging (13 papers), Lung Cancer Research Studies (6 papers) and Head and Neck Cancer Studies (6 papers). Giorgio Astara collaborates with scholars based in Italy, United States and Brazil. Giorgio Astara's co-authors include Clelia Madeddu, Antonio Macciò, Giovanni Mantovani, Giulia Gramignano, Elena Massa, Roberto Serpe, Maria Rita Lusso, Laura Deiana, Mariele Dessì and E. Sanna and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
In The Last Decade
Giorgio Astara
47 papers receiving 1.2k citations
Peers
Giorgio Astara
Crystal N. Holick United States
Dieuwertje E. Kok Netherlands
M J Stampfer United States
R. Giorgino Italy
G. Berglund Sweden
Aaron R. Folsom United States
Cindy K. Blair United States
Prudence R. Carr Germany
Larry E. Fields United States
P. Lagiou Greece
Citations per year, relative to Giorgio Astara Giorgio Astara (= 1×)
peers
Crystal N. Holick
Countries citing papers authored by Giorgio Astara
Since
Specialization
Citations
This map shows the geographic impact of Giorgio Astara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Astara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Astara more than expected).
Fields of papers citing papers by Giorgio Astara
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Giorgio Astara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Astara. The network helps show where Giorgio Astara may publish in the future.
Co-authorship network of co-authors of Giorgio Astara
This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Astara. A scholar is included among the top collaborators of Giorgio Astara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Astara. Giorgio Astara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Pretta, Andrea, Eleonora Lai, Mara Persano, et al.. (2022). Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment. World Journal of Hepatology. 14(7). 1319–1332.
2.
Liscia, Nicole, Annagrazia Pireddu, Laura Demurtas, et al.. (2021). 2P Role of neutrophil-to-lymphocyte ratio (NLR) in the outcome of NSCLC EGFR mutated. Journal of Thoracic Oncology. 16(4). S699–S700.
3.
Casadei‐Gardini, Andrea, Giulia Rovesti, Vincenzo Dadduzio, et al.. (2020). Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib. HPB. 23(6). 915–920.
4.
Madeddu, Clelia, Giulia Gramignano, Giorgio Astara, et al.. (2018). Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach. Frontiers in Physiology. 9. 1294–1294.
5.
Astara, Giorgio, Eleonora Lai, Mariele Dessì, et al.. (2017). Medical management of malignant bowel obstruction: our center experience. Annals of Oncology. 28. vi15–vi15.
6.
Puzzoni, Marco, Nicola Silvestris, Francesco Leone, et al.. (2016). The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?. Targeted Oncology. 11(5). 593–603.
7.
Orgiano, L., Fabiana Pani, Giorgio Astara, et al.. (2016). The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience. Supportive Care in Cancer. 24(10). 4293–4299.
8.
Astara, Giorgio, Clelia Madeddu, Valeria Ruggiero, et al.. (2015). Osteopontin (OPN) and interleukin-6 (IL-6) as predictive biomarkers in HCC receiving loco-regional treatment: preliminary results. Annals of Oncology. 26. vi104–vi104.
9.
Macciò, Antonio, Clelia Madeddu, Giulia Gramignano, et al.. (2010). Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications. Journal of Molecular Medicine. 88(7). 677–686.
10.
Macciò, Antonio, Clelia Madeddu, Daniela Massa, et al.. (2008). Interleukin‐6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients. Journal of Cellular and Molecular Medicine. 13(9b). 3951–3959.
11.
Massa, Elena, Clelia Madeddu, Giorgio Astara, et al.. (2008). An attempt to correlate a “Multidimensional Geriatric Assessment” (MGA), treatment assignment and clinical outcome in elderly cancer patients: Results of a phase II open study. Critical Reviews in Oncology/Hematology. 66(1). 75–83.
12.
Massa, Elena, et al.. (2008). Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response. Critical Reviews in Oncology/Hematology. 70(1). 83–91.
13.
Gramignano, Giulia, Maria Rita Lusso, Clelia Madeddu, et al.. (2006). Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition. 22(2). 136–145.
14.
Astara, Giorgio, Elena Massa, Francesca Maria Tanca, et al.. (2005). The 'comprehensive geriatric assessment' (CGA) as an instrumental tool for therapeutic decision making and the correspondent evaluation of clinical outcome in elderly cancer patients. Annals of Oncology. 16(7). 73–73.
15.
Mantovani, Giovanni, Clelia Madeddu, Giulia Gramignano, et al.. (2003). Subcutaneous interleukin‐2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters. PubMed. 3(4). 205–219.
16.
Mantovani, Giovanni, Elena Massa, Giorgio Astara, et al.. (2003). Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs. Oncology Reports. 10(1). 197–206.
17.
Mantovani, Giovanni, et al.. (2000). Endoscopic Laser Ablation as Palliative Treatment of Endobronchial, Nonresectable, or Recurrent Lung Cancer: Assessment of its Impact on Quality of Life. Clinical Lung Cancer. 1(4). 277–285.
18.
Mantovani, Giovanni, Giorgio Astara, Alessandro Bianchi, et al.. (1996). Evaluation by multidimensional instruments of health-related quality of life of elderly cancer patients undergoing three different “psychosocial” treatment approaches. Supportive Care in Cancer. 4(2). 129–140.
19.
Astara, Giorgio, et al.. (1995). Primary T Cell CD30-Positive Anaplastic Large-Cell Lymphoma Associated with Adult-Onset Celiac Disease and Presenting with Skin Lesions. Acta Haematologica. 94(1). 48–51.
20.
Mantovani, Giovanni, Antonio Macciò, Giorgio Astara, et al.. (1993). Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies. Cell Biochemistry and Biophysics. 22(1-3). 79–99.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Crystal N. Holick Breakdown of academic impact, for papers by Dieuwertje E. Kok Breakdown of academic impact, for papers by M J Stampfer Breakdown of academic impact, for papers by R. Giorgino Breakdown of academic impact, for papers by G. Berglund Breakdown of academic impact, for papers by Aaron R. Folsom Breakdown of academic impact, for papers by Cindy K. Blair Breakdown of academic impact, for papers by Prudence R. Carr Breakdown of academic impact, for papers by Larry E. Fields Breakdown of academic impact, for papers by P. Lagiou